Novelix Pharmaceuticals share news and announcements
BSE: 536565Healthcare ServicesSmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹62.73.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹170 Cr2,861st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 13 Aug 2026
- 46.7
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- 11.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- 8.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.09
- Volume, BSEVolume. Shares traded on the last trading day.
- 1,524
Novelix Pharmaceuticals share news and announcements
605 announcements, routine notices left out, newest first. Page 2 of 13.
May 2026
5 May · Intimation Under Regulation 30 (LODR) Regulations, 2015- Website Address.
Apr 2026
Mar 2026
31 Mar · Announcement under Regulation 30 (LODR)-Allotment
31 Mar · Intimation Under Regulation 30 (LODR), Regulations 2015- Reconstitution Of Committees.
30 Mar · Board meeting
Feb 2026
12 Feb · Announcement under Regulation 30 (LODR)-Allotment
12 Feb · Results
9 Feb · Board meeting
Meeting on 12 Feb 2026: quarterly results
Jan 2026
20 Jan · Announcement under Regulation 30 (LODR)-Allotment
19 Jan · Board meeting
Meeting on 19 Jan 202619 Jan · Board meeting
10 Jan · Management
10 Jan · Results
Dec 2025
25 Dec · Announcement under Regulation 30 (LODR)-Allotment
24 Dec · Board meeting
21 Dec · Intimation Under Regulation 30 (LODR) 2015- Lease
8 Dec · Board meeting
Meeting on 11 Dec 2025: preferential issue of shares
Nov 2025
14 Nov · Intimation Of Reconstitution Of Committees.
10 Nov · Board meeting
Meeting on 13 Nov 2025: quarterly results
Oct 2025
23 Oct · Announcement under Regulation 30 (LODR)-Allotment
23 Oct · Management
23 Oct · Board meeting
Meeting on 23 Oct 202523 Oct · Board meeting
17 Oct · Business
16 Oct · Business
Sep 2025